DxPx Conference for Investors

WORLD SERIES OF INDUSTRY & INVESTOR PARTNERING CONFERENCES FOCUSING ON DIAGNOSTICS, DIGITAL HEALTH, PRECISION MEDICINE & LIFE SCIENCE TOOLS 
0

Square feet

0

Startup city kiosks

0

One-on-one meeting cubicles

0

Investors

0

Speakers

0

Panel discussions

0

US funding opportunity

Discover innovative startups and meet other investors. Network the DxPx way.

As startup founders and investors, ourselves, we understand how challenging it can be to keep track of new technology trends, expand our network and promote our businesses. That’s why we organize DxPx with the heart and soul of it being partnering and networking. With the gaining importance of diagnostics, digital health, precision medicine, and life science tools there is a need for a dedicated platform to bring together the relevant stakeholders and further drive our industries.

dxpx-investors-003

Evaluate innovative investment opportunities

For the first time ever, we are building a Startup City in the US, and having all these innovative companies in one huge space of 20,000 sft/2,000 sqm is an unprecedented opportunity for investors to discover new ventures. Having built a huge community of startups in the US is one of the reasons why we are bringing DxPx US in the flesh this year at AACC, McCormick Place, Chicago. Exchanging ideas and talking about innovation with all these companies would be a huge leap in bringing people in the same field together in one room.  

Building a Startup City focusing on Diagnostics, Digital Health, Precision Medicine, and Life Science Tools is what we are aiming for so that more valuable businesses come to life and grow. Matchmaking the relevant investors and industry leaders to a particular startup or growth company are one of the best outcomes we are looking forward to from this partnering conference.  

Watch panel discussions with leading industry experts on the latest innovations in diagnostics

The advantages of participating in the DxPx US are obvious since it is happening in person for three days, you will encounter more insightful panel discussions, more riveting fireside chats, and more time for partnering & networking. Knowledge transfer at the highest level, indeed! Learn from industry experts, strategic investors as well as successful entrepreneurs from your field who share their experiences and strategies for complex current and future issues.  

At DxPx you can not only hear them speak but also schedule one-to-one meetings with the panelists in our partnering tool or face-to-face. 

dxpx-investors-004

Here are topics to watch out for in the upcoming conference:

  • European Startups: Undervalued opportunities for US investors?!
  • The future of AI in health care.
  • Upscaling & manufacturing in Cell & Gene Therapies – Current challenges and solutions.
  • Establishing a new diagnostics gold marker.
  • Post-merger integrations in life sciences. The good, the bad, the ugly.
  • Value-based medicine: What is realistic and what is needed.

Build new and strengthen professional relationships  

DxPx, hosted as the Investor and Industry Partnering Conference, is exactly the right place, especially when it comes to networking. Here are the opportunities and experiences that await you at the DxPx:  

  

  • 3 Days In Person Meetings – this will provide more time for investors, industry leaders, and startups to have one-to-one partnering. You will have access to all exhibitions, networking, startup city area, fireside chats, and panel discussions, too.  

  

  • 2 Weeks Digital Partnering – this is an option for those who can’t join in person (ideally, we want to meet you in person, but we are making this conference hybrid to cater to the needs of everyone). With our AI-assisted professional partnering platform/app, matchmaking is seamless.  

  

  • DxPx Rooftop Reception – be inspired and have fun networking in a private atmosphere. Food and drinks are included! Chicago is known for its gorgeous skylines and one of the best ways to see them is by viewing them from one of the rooftops (therefore we are having our reception at the VU Rooftop Bar, Hiltons at McCormick Place!). Only in combination with in person tickets.  

  

Configure your individual partnering experience in the ticket shop 

dxpx investors 001

Why this DxPx is not like the previous ones and why do we want you to be there?

  • For the first time ever, we are organizing the DxPx US for three days in person to pave the way for more partnering and networking opportunities for all types of participants.  
  • We are holding this conference in a huge venue of 20,000 square feet at the AACC Clinical Lab Expo in McCormick Place, Chicago from July 26th to 28th.  
  • Apart from your DxPx Conference participation, each DxPx participant will also get a code for a free ticket to AACC’s Clinical Lab Expo, the world’s foremost global event for diagnostics and laboratory medicine from July 26 – 28. This grants you access to the Expo Hall, Exhibit Hall Theatre, Industry Workshops, Hotel Industry Workshops, and Lecture Series Presentations. Participating in the DxPx US Conference means hitting two birds with one stone!  

2 Weeks Digital Partnering

€ 480

Free

3 Days In Person Meetings

980

McCormick Place, Chicago at

Clinical Lab Expo

DxPx Rooftop Reception

250

VU Rooftop Bar, Hiltons at McCormick Place
On the 27th of July starting at 7pm

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience